Table 3.
Characteristics of confirmed SARS-CoV-2 infected patients with 2 consecutive negative tests.*
| Positive | Negative | P value | |
|---|---|---|---|
| Female sex | 18/38 (47.4%) | 61/109 (56.0%) | .36 |
| Severe | 10/38 (26.3%) | 28/109 (25.7%) | .939 |
| Age (yr) | 61.50 (45.00–71.00) | 63.00 (52.00–68.00) | .965 |
| Characteristics on admission | |||
| Days from onset to admission | 13.50 (9.00–21.00) | 10.00 (6.00–19.00) | .034 |
| Days from onset to consecutive negative tests | 30.5 (22.00–39.00) | 30.00 (26.00–37.50) | .639 |
| Days from first negative to consecutive positive tests | 6.00 (4.00–10.00) | - | - |
| Lymphocyte count, × 109/L | 1.24 (1.00–1.55) | 1.29 (0.98–1.68) | .624 |
| Eosinophil count, × 109/L | 0.06 (0.02–0.12) | 0.06 (0.01–0.11) | .445 |
| Lactate dehydrogenase, U/L | 206.50 (149.50–271.50) | 200.00 (171.00–262.00) | .957 |
| IL6, pg/mL | 16.55 (6.81–25.99) | 12.30 (5.13–36.25) | .941 |
| IL10, pg/mL | 3.97 (2.96–5.06) | 3.24 (2.68–3.81) | .104 |
Data are median (IQR) or n/N (%), where N is the total number of patients with available data. P values are comparing the positive group and the negative group from χ² test or Mann–Whitney U test. P < .05 was considered statistically significant.
SARS-CoV-2 = 2019 severe acute respiratory syndrome coronavirus 2.
*
This table shows characteristics of the confirmed infected patients who received more tests of SARS-CoV-2 after 2 consecutive negative results and were divided into positive and negative groups according to the test results. The non-respiratory specimens were excluded from calculation.